Background and Significance: The application of heavy ion beams in cancer therapy must account for the increasing relative biological effectiveness (RBE) with increasing penetration depth when determining dose prescriptions and organ at risk (OAR) constraints in treatment planning. Because RBE depends in a complex manner on factors such as the ion type, energy, cell and tissue radiosensitivity, physical dose, biological endpoint, and position within and outside treatment fields, biophysical models reflecting these dependencies are required for the personalization and optimization of treatment plans. Aim: To review and compare three mechanism-inspired models which predict the complexities of particle RBE for various ion types, energies, linear energy transfer (LET) values and tissue radiation sensitivities. Methods: The review of models and mechanisms focuses on the Local Effect Model (LEM), the Microdosimetric-Kinetic (MK) model, and the Repair-Misrepair-Fixation (RMF) model in combination with the Monte Carlo Damage Simulation (MCDS). These models relate the induction of potentially lethal double strand breaks (DSBs) to the subsequent interactions and biological processing of DSB into more lethal forms of damage. A key element to explain the increased biological effectiveness of high LET ions compared to MV x rays is the characterization of the number and local complexity (clustering) of the initial DSB produced within a cell. For high LET ions, the spatial density of DSB induction along an ion's trajectory is much greater than along the path of a low LET electron, such as the secondary electrons produced by the megavoltage (MV) x rays used in conventional radiation therapy. The main aspects of the three models are introduced and the conceptual similarities and differences are critiqued and highlighted. Model predictions are compared in terms of the RBE for DSB induction and for reproductive cell survival. Results and Conclusions: Comparisons of the RBE for DSB induction and for cell survival are presented for proton ( 1 H), helium ( 4 He), and carbon ( 12 C) ions for the therapeutically most relevant range of ion beam energies. The reviewed models embody mechanisms of action acting over the spatial scales underlying the biological processing of potentially lethal DSB into more lethal forms of damage. Differences among the number and types of input parameters, relevant biological targets, and the computational approaches among the LEM, MK and RMF models are summarized and critiqued. Potential experiments to test some of the seemingly contradictory aspects of the models are discussed.
INTRODUCTION
Hadron therapy, [1] [2] [3] mostly using protons and carbon ions, is advantageous for the treatment of some cancers, and the number of treatment facilities throughout the world continues to increase. As of 2018, there are 11 carbon ion facilities (5 in Japan, 2 in Germany, 2 in China, 1 in Austria, and 1 in Italy) and 69 proton therapy centers (27 in the USA, 13 in Japan, 6 in Germany, and remainder spread among 14 countries).* Hadron therapy with helium and other ions has been used in the past [4] [5] [6] [7] [8] and is still of potential interest in cancer therapy. [9] [10] [11] [12] [13] To fully exploit the potential of high-linear energy transfer (LET) hadron therapy and leverage the many decades of experience treating cancer with low-LET radiations, such as 60 Co c rays or megavoltage (MV) x rays, an understanding of the biological effectiveness of higher LET particles relative to a low LET reference radiation is essential.
The relative biological effectiveness (RBE) of an ionizing particle is defined as the ratio of the absorbed dose of a usually low LET reference radiation to the absorbed dose of an ionizing particle that produces the same biological effect. For proton therapy treatment planning, an constant RBE of 1.1 is typically used regardless of the clinical endpoint and underlying biology.
14, 15 An RBE of 1.1 implies that proton doses are, on average, about 10% more biologically damaging than MV x rays. However, spatial variations in proton RBE (e.g., close to the field edges and beyond the distal Bragg peak) have the potential to increase treatment complications or, alternatively, are a potential missed opportunity to enhance local control. Because carbon ions in the therapeutic energy range have a much higher LET than therapeutic protons, spatial variations in carbon ion RBE within tumor targets and nearby organs at risk (OAR) are much greater than the spatial variations in RBE likely in proton therapy. In carbon ion therapy, the RBE can vary from close to 1.0 to 1.3 where a beam is incident on the patient (e.g., skin RBE) up to 3 or more within tumor targets close to the field edges and distal to the Bragg peak.
Although the initial induction of DNA double-strand breaks (DSBs) and other types of clusters of DNA lesions are proportional to absorbed dose up to at least a few hundred or thousand Gray (Gy) (reviewed in Ref. [16, 17] ), chromosome aberrations and reproductive cell survival often exhibit a linear or linear-quadratic (LQ) dose-response characteristics. [18] [19] [20] [21] [22] [23] Local tumor control and normal-tissue toxicity arising from the treatment of cancer (i.e., clinical endpoints) are also highly nonlinear functions of the absorbed dose. [24] [25] [26] [27] Cellular, tumor, and tissue responses are ultimately sensitive to the total treatment dose, fraction size, and temporal pattern of radiation delivery over minutes and hours because of, for example, DNA repair kinetics (e.g., Ref. [28, 29] ) and over days or weeks because of the effects of cell proliferation 30, 31 and other tissue or tumor biology, such as the so-called four or five R's of radiation biology. 32 Because of the multitude of the factors and mechanisms of action underlying tumor and normal tissue responses to radiation therapy, particle RBE also depends on many biological, patient-and treatment-specific factors, including the particle type, incident beam energy, and number and types of treatment fields. [33] [34] [35] [36] [37] [38] [39] Because particle RBE is a ratio of the doses of radiations that produce the same biological effect, it is important to note that the biology and treatment factors (e.g., total dose and fraction size) used as low LET reference radiation are as important to accurate determinations of clinical RBE as particle beam biology and treatment factors. For all of these reasons, mathematical models of particle RBE are essential for efforts to translate the results of in vitro and in vivo experiments probing mechanisms of action to the clinical setting, thus facilitating the optimization and personalization of hadron therapy treatment planning. 37 , [39] [40] [41] [42] [43] The three mechanism-inspired RBE models considered here are the local effect model (LEM), [44] [45] [46] the microdosimetric-kinetic (MK) model, [47] [48] [49] [50] [51] and the repair-misrepairfixation (RMF) model. 11, 41, [52] [53] [54] The original version of LEM, referred to as LEM I, as well as the MK model are in routine clinical use for carbon ion treatment planning [55] [56] [57] [58] and have been implemented in commercially available treatment planning systems (LEM: Syngo RT, Siemens, Erlangen, Germany, and LEM + MK: RayStation, RaySearch Laboratories AB, Stockholm, Sweden). The RMF and an improved version of LEM, referred to as LEM IV, have also been implemented into research-oriented treatment planning systems 40, 41, [59] [60] [61] and other RBE modeling platforms. 54 Many different approaches have been developed to model the shape of dose-response curves after photon irradiation. In contrast, comparably few models have been developed to specifically predict the increased effectiveness of ion beam radiation. These RBE models need to establish a link between the energy deposition pattern and the expected biological response. This translation of the energy deposition into the observed biological effect includes numerous complex processes and pathways, many of which are still poorly understood or at least not quantified; thus, models necessarily represent an approximate representation of the underlying biological processes and response. One of the major challenges of modeling in the framework of treatment planning is therefore to find the right balance between accuracy and model complexity, that is, the number of different processes and mechanisms to be taken into account. A direct comparison of model predictions, and also of the underlying concepts, is therefore of utmost importance in order to elucidate the similarities and differences in the models that can be used for biological optimization in ion beam treatment planning. The identification of potential scenarios that allow discrimination between models represents a further important aspect, requiring the direct comparison of model predictions.
In the present study, we compare and contrast the LEM IV, MK, and RMF models for the prediction of the RBE for reproductive cell survival. The RBE for cell survival is usually considered the most relevant cellular endpoint for the prediction of the RBE for clinical endpoints, although work to test this hypothesis is ongoing. Because the RMF model requires an auxiliary model to determine the RBE for DSB induction (RBE DSB ), the Monte Carlo Damage Simulation (MCDS) 16, 17, 52, [62] [63] [64] [65] [66] is also reviewed and compared to the LEM IV track structure model for DSB induction. Although all these models have been published and compared to experimental data, a critical review of the practical and conceptual basis of all three models along with direct and quantitative comparisons of all the models has not been published. In this paper, some of the main authors of the LEM, MK, and RMF models have undertaken a comprehensive review of the mechanisms of action, model inputs and parameters, and practical aspects of these models. The publication is organized as follows. First, the models are introduced and key model inputs and mechanisms are reviewed. Then, quantitative estimates of particle RBE for the endpoints of DSB induction and reproductive cell survival are presented for selected ions (protons, helium, and carbon ions) over the therapeutically most relevant range of kinetic energies. The results of the comparison are discussed and compared within the context of postulated mechanisms as well as the overall trends in the RBE predicted by all three models. Some recommendations for future experiments that would provide new information to further test alternative mechanisms of action and hypotheses are provided.
RBE MODELS AND MECHANISMS OF ACTION
The MK model of Hawkins, [47] [48] [49] [50] the most recent version of the LEM, 35, 45, 46 and the RMF model 40, 41, [52] [53] [54] 61 are examples of mechanism-inspired models that link the RBE for reproductive cell survival to the induction and biological processing of sublethal damage, especially the DNA DSB, into more lethal forms of damage, such as chromosome aberrations. The MK, LEM, and RMF models all aim to derive the biological effects of ion radiation from the response of cells or tissues to low LET photons, thus efficiently exploiting the large amount of in vitro and in vivo data in the literature. 35, [67] [68] [69] [70] [71] [72] [73] All three models provide quantitative frameworks to estimate trends in the LQ model radiation sensitivity parameters a, b (or a/b) as a function of linear energy transfer (LET), lineal energy (y), or other metrics of radiation quality, such as the square of the ratio of the effective charge of the ion (Z eff ) divided by the speed of the ion relative to the speed of light (b). In general, particle LET (and lineal energy) increases with increasing (Z eff /b) 2 up to a particle-specific peak and then begins to decrease. As a first approximation, the dosemean lineal energy is equal to the unrestricted stopping power of the ion, 74 that is, yðDÞ ffi LET 1 for the case of monoenergetic beams. For the endpoint of reproductive cell survival, assuming the LQ approach fully describes the data, the RBE as a function of ion dose (fraction size) D can be computed using the formula.
where RBE LD (a ion /a R ) and RBE HD (b ion /b R ) 1/2 . The subscript R indicates a radiosensitivity parameter for the low LET reference radiation (e.g., MV x rays or c rays from 60 Co) and the subscript ion indicates a charged particle with a specific kinetic energy, LET, lineal energy (y D ), and (Z eff /b) 2 . In the limit when D becomes small compared to (a/b) R , RBE(D) approaches the value of the low-dose RBE (i.e., RBE LD ). As D becomes large compared to (a/b) R , RBE(D) approaches the high-dose RBE (i.e., RBE HD ). Alternate, but mathematically equivalent, RBE formulas based on the LQ cell survival can be widely found in the literature. 49, 53, 61, 75, 76 Equation (1) is written to emphasize that RBE(D) only depends on (a/b) R and on the dimensionless ratios of (a ion / a R ) and (b ion /b R ). Both MK and RMF make use of the LQ model for RBE calculations, whereas the LEM IV uses a modified LQ-approach to transition back to a linear shape for doses larger than a threshold D t. 44 This LQ-L approach is one way to potentially improve the accuracy of the LQ model in the limit as the dose becomes large compared to (a/b). The high-dose (linear) correction used in the LEM IV is usually small for clinically relevant determinations of RBE(D).
In the MK and RMF models, mechanism-inspired formulas are developed to predict trends in (a ion /a R ) and (b ion /b R ) and then Eq. (1), or a mathematically equivalent formula, is used to compute RBE(D) for a cell-, tumor-, or tissue-specific value of (a/b) R . The RMF model explicitly relates changes in (a ion /a R ) and (b ion /b R ) to the RBE for DSB induction (RBE DSB ) as a function of (Z eff /b) 2 . The MK model directly parameterizes (a ion /a R ) and (b ion /b R ) in terms of LET (or lineal energy) without making specific assumptions about the induction of DSB or other types of molecular damage. The LEM IV is a multiscale system of models that combines an analytical model for the threedimensional (3D) dose distribution in the cell nucleus and along individual tracks with a simple Monte Carlo simulation of DSB induction, from which cell survival and the RBE(D) is be calculated.
2.A. LEM IV
The LEM makes use of the concept of the "local dose," which is defined as the expectation value of the energy deposition at any position in the radiation field for a given pattern of particle trajectories. The main assumption of the LEM is that equal local doses lead to equal local effects, independent on the radiation quality. This local dose is derived from an analytical amorphous track structure representation of the energy deposition as a function of the radial distance to the particle trajectory. The effectiveness of particles is thus calculated based on the microscopic local dose distribution pattern of ion traversals within the cell nucleus, assuming the nucleus to be the sensitive target for the observed radiation effects, which is assumed to be homogeneously filled with DNA ( Fig. 1) .
Although the first version of the LEM (called LEM I 44 ) is still in clinical use, only the most recently version of the model (LEM IV 45, 46 ) is described and considered in this paper; a detailed analysis of the impact of the underlying changes between the LEM I and IV in treatment planning is reported elsewhere. 59 However, in brief, the impact of the corresponding model improvements becomes visible essentially in two aspects. The first is related to the steeper gradient in particle LET with increasing LET in the LEM IV as compared to LEM I; comparisons with experimental data
regarding the tolerance of the nervous system, which are of particular interest for clinical applications, provide some evidence that this steeper gradient is more realistic than the gradient predicted in LEM I. 77, 78 The second aspect is related to the better simultaneous agreement of model predictions of particle RBE in vitro over a broader range of therapeutically relevant ion species and energies (i.e., protons up to carbon ions) without the need for parameter optimization for individual ion species. 45, 79 Applications of LEM I in the clinical environment are most accurate for carbon ions. The used set of parameters typically leads to a systematic overestimation of RBE for lighter ions, including protons. In the LEM IV, this shortcoming of the LEM I was resolved by developing a model for DSB induction, as described below, which allows to account more explicitly for damage clustering.
To calculate cellular effects like, for example, cell killing for a given local (nanometer-and micrometer-scale) dose deposition pattern, an intermediate step is introduced, based on the premise that the final biological response of a cell to various radiation types is directly linked to the induced initial spatial DNA damage distribution rather than the local dose distribution itself. It is assumed that the microscopic (subnuclear) spatial distribution of DSB represents a relevant determinant of cell fate after irradiation. Furthermore, the plausible conjecture is used that similar spatial patterns of DSB induction lead to similar effects, independent of the radiation quality leading to these patterns of DSB induction.
In order to assess the similarity of DSB distributions, specific measures have to be defined. In the LEM IV, the structure of chromatin organization in the cell nucleus is considered for this purpose. It is assumed that so-called "giant loops" of chromatin, 80, 81 comprising about 2 Megabase pair (Mbp) of DNA, represent the critical DNA structure. 82, 83 Two types of damage are distinguished, namely that either Based on the knowledge of the local dose distribution within the cell nucleus (left side), the distribution of DSB within the nucleus and within subcompartments of the nucleus corresponding to giant chromatin loops (middle part) is determined. The relative fractions of isolated DSB (iDSB) and complex DSB (cDSB) determine the overall complexity of damages, which is used to determine the effectiveness of particle radiation from the known response to photon radiation (right side). (b) LEM IV predictions of RBE as a function of LET for He ions and C ions in comparison to experimental data obtained for HSG cells (Furusawa et al. 133 ). For protons, only model predictions are shown, as no experimental data were available from the corresponding study for proton irradiation.
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Stewart et al.: Mechanistic particle RBE models e928 only a single DSB ("isolated DSB," iDSB) is induced in such a loop structure, or two or more DSB ("clustered DSB," cDSB) are induced. It is hypothesized that cDSB lead to a significantly higher probability of, for example, cell killing as compared to iDSB, since for iDSB the DNA on both sides of the DSB is still attached to the nuclear matrix, and thus repair is expected to be facilitated in general in this case. In contrast, for cDSB, one or more DNA fragments can be removed from the loop, which are not any longer attached to the nuclear matrix and thus correspondingly difficult to repair. Assuming that damage induced in different DNA loops can be considered to act independently, the proportion of the total number of loops with iDSB and cDSB represents a measure of the clustering of the DSB induced by a given dose distribution, and can be formalized by the cluster index C 45 :
where N cDSB and N iDSB represent the number of loops with isolated and clustered DSB, respectively. Qualitatively, a larger cluster index indicates a higher spatial proximity of DSB, which bears a higher potential for DSB interaction in chromatin loops.
Technically, the calculation of the spatial DSB distribution is based on the local dose derived as an amorphous track structure radial dose profile as mentioned above. Note that the calculation of this radial dose profile corresponds to an ensemble average over many tracks, but reflects an unlimited spatial accuracy. Assuming a homogeneous distribution of the DNA within the nucleus, the dose distribution serves as a probability density distribution, from which the mean number of DSB in any small subvolume of the nucleus can be derived by using the yield of radiation-induced DSB of approximately 30 DSB Gy À1 cell À1 (5 DSB Gy À1 Gbp À1 ) as obtained for photon radiation. In addition, due to interaction of SSB, a nonlinearly increasing number of DSB with the local dose is taken into account, which is relevant in dose regimes substantially exceeding hundreds of Gy, as often reached in the inner parts of ion tracks. Based on the thereby calculated average number of local DSB per unit volume from the amorphous track structure model, the (x,y,z) locations of individual DSB are determined using Monte Carlo random sampling from the probability density distribution for DSB.
In order to determine the number of isolated and clustered DSB, the cell nucleus is divided into cubic-shaped subvolumes with 540 nm side length, corresponding to the volume typically covered by a 2 Mbp DNA content when assuming a homogeneous distribution of DNA within the nucleus [see Fig. 1(a) ]. The number of DSB in each subvolume is determined according to the local dose distribution within the subvolume, and the subvolumes are then classified as iDSB or cDSB if exactly one DSB or two or more DSB are induced in a subvolume, respectively. The cluster index can be directly evaluated from the Monte Carlo simulations.
In order to determine the observable biological effect (i.e., number of lethal lesions) of a given spatial DSB pattern, in a first step the photon dose that leads to the same damage complexity C, that is, the same relative composition of iDSB and cDSB, is determined. In a second step, the effect produced by that equivalent photon dose is determined from the photon dose-response curve. Typically, the ion induced lesions only cover a corridor within the nucleus, while with photons cells are homogeneously exposed, leading to more overall lesions at equal complexity. Therefore, in a final step, the ion effect is equated as the effect of the photon equivalent situation after appropriate scaling by a factor j, corresponding to the total number of iDSB or cDSB that are induced by a particle traversal with respect to those induced by the photon equivalent dose.
Here, D ion denotes the dose deposition by a single particle traversal, S ion (D ion ) and S R (D eq ) denote the survival after ion radiation at dose D ion and photon irradiation with the photon equivalent dose D eq , respectively. The quantity N with the corresponding subscripts represents the numbers of isolated and clustered DSB after ion and photon radiation, respectively. Within this procedure, the photon dose-response curve is represented by the LQ parameters a R and b R for the specific biological endpoint under consideration, which are known from experiments or clinical data. Because the LQ model is less accurate for high doses larger than (a/b) and typically underestimates survival in this dose region, empirical or semiempirical methods are sometimes used to straighten the cell survival response (on a semi-log scale) at high dose. [84] [85] [86] [87] For low (a/b) cells, corrections may be useful for doses as low as 5-10 Gy. For cells with a large (a/b), the LQ may suffice for doses as large as 15-18 Gy. 88, 89 The LEM IV transitions from an LQ shape back to a linear shape for D > D t 44 where D t is a cell or tissue-specific "threshold" dose. To calculate the RBE from the effects, the conventional LQ formalism can be used, again recalling the photon dose-response curve.
Because of the complex 3D patterns of DSB induced by the particle traversals, analytical determinations of D eq and the ion effect from Eqs. (2) and (3) are usually not feasible. Therefore, Monte Carlo methods and numerical techniques are used to determine those quantities. The computational procedure is carried out for many cells (typically~10 4 to 10 6 ) to account for the stochastic aspects of DSB formation within critical subnuclear structures (i.e., chromatin loops). The model permits the rapid calculation of the effect of a single particle traversal, defining the effectiveness at low doses and thus the a ion term of the LQ representation of the dose-response curve. The b ion term can then be estimated according to the approximation described in Ref. [57] , and reflects the interaction of DSB between different ion tracks. This approximation has been introduced since full simulation dose-response curves, based on the detailed representation of stochastic particle distributions, would be unfeasible for applications in the framework of treatment planning; this was mainly due to the extremely time consuming calculations. Summarizing, the increased number and proximity of DSB within ion tracks is the key factor that LEM uses to express the enhanced radiation effectiveness of ions, as it enables the formation of more severe lesions by clustering within subnuclear domains. Figure 1 (b) shows a typical example of LEM IV predictions for the RBE of protons, helium ions, and carbon ion beams and the corresponding experimental data for HSG cells (for protons only model predictions are shown because experimental data for HSG cells were not available from the corresponding study). The model correctly describes the general shape of the RBE(LET) relationship and in particular the shift between the curves for individual ion species, which can be traced back to the differences in track structure between different ion species at a given LET. Good agreement of LEM IV predictions with experimental data has also been found for other cell lines in vitro under track-segment conditions, 45 in mixed fields, 10, 45, 79 for oxygen ions, 90 and also for biological effects in vivo, 91 including fractionated irradiation. 78 The model uses a set of fixed parameters that are identical for all calculations and of variable parameters which are specific for individual experiments. 46 The variable parameters characterize the biological properties of the target (r N ), the dose-response after photon radiation (a R , b R , D t ), and the physical radiation properties (E, LET). Aside from D t , all parameters represent measurable quantities; D t is typically estimated based on an empirical formula. A list of default and input parameters that need to be determined to compute particle RBE using the LEM IV are summarized in Table I .
2.B. MK Model
The MK model [47] [48] [49] [50] is an elaboration of the site model version of the theory of dual radiation action (TDRA) 92, 93 combined with a mass-action kinetic model 8, 94 for the repair or conversion into a lethal unrepairable lesion (chromosome aberration) of the primary potentially lethal radiation-induced lesions in DNA (PLL). The formation of a lethal lesion can occur, for example, through the binary combination of two PLL to form a dicentric chromosome and/or acentric fragments or by monolesional severance of the DNA strand to form an acentric fragment. The PLL are likely what are measured as a DSB.
The cell nucleus is regarded as divided into compartments called domains, which are defined so that PLL are confined to the domain in which they are created. Thus, a pair of PLL can only combine to form a lethal lesion if they are created in the same domain. Domains have a variety of shapes and fit together to fill the nucleus. If deformed to a sphere of unit density, all domains are assumed to have the same diameter (d). Thereby the notion of domain is introduced to account for the interaction of two PLL in close spatial proximity. Restrictions on the thermal motion of a PLL from the tethering of the DNA to the nuclear matrix or membrane are examples of how PLL in distant parts of the same or a different chromosome might be unable to interact during the finite lifetime of a PLL due to repair.
Let 〈w〉 be the average number of lethal lesions per cell and S be the surviving fraction of cells after instantaneous exposure to dose D of ionizing radiation. The MK model implies that Since values for the nuclear volume are not explicitly mentioned in most publications, this represents a reasonable standard value that is used unless other information is available.
c Cell-and tissue-specific input determined from fits to measured data.
The subscript P indicates that the relationship holds when there is a Poisson distribution of lethal lesions among the irradiated cell population. The subscript R, again, designates a symbol that relates to the low LET reference radiation. The parameter y D is the dose-weighted lineal energy (in units of keV/lm) of the radiation, which is approximately equal to the particle's LET. Likewise, y DR is the dose weighted lineal energy of the reference radiation. It is measurable with a tissue equivalent proportional counter (TEPC) consisting of a test volume of tissue equivalent gas with density adjusted so that ionizing radiation will experience the same mean energy loss as it would in a spherical volume of tissue with diameter d equal to that of a target or domain-size of interest. Fortunately, the value of y D measured with a TEPC is relatively insensitive to the range of chamber diameters relative to cellular and subcellular microdosimetry [see eq. (A.11) in Ref. [74] ]. The decimal constant 0.204 in Eqs. (4) and (5) emerges when expressing the microdosimetric specific energy in terms of the lineal energy for spherical site volumes, and furthermore includes unit conversion constants that allow to directly use lineal energy in keV/lm and the site volume in lm in the equations (see appendix of Ref. [74] ). Equations (4) and (5) are developed with the implicit understanding that the mass density within the subcellular domains is 1 g cm À3 . The match of the effective diameter of the TEPC to that of a domain needs not be exact. For Cobalt-60 c rays, y DR = 1.8 keV/lm, and for 250 kVp x rays, y DR = 4.7 keV/ lm. 74 The value of y D is an expression of radiation quality that can be used as an alternative to the dose-averaged LET with infinite delta-ray cutoff (i.e., the charged particle stopping power). If delta ray escape from a domain is negligible, LET = (8/9)y D for spherical domain volumes. 74 Most experimental studies of RBE express radiation quality in terms of LET rather than y D , although there is at least one study by Kase et al. 95 that reports results in terms of y D . The data shown in Fig. 2 are based on particle LET rather than y D .
The value of RBE 1P is the relative biological effectiveness in the limit of zero dose. The relation -ln S = 〈w〉 holds for Poisson distribution of lethal lesions among the cells of the irradiated population, which is the case for LET less than about 50 keV/lm. The decimal constant is such that the bracketed coefficient of D in Eq. (4) (which equals a) is in units of Gy À1 if d is in lm and y D in units of keV/lm. The parameters a R and b R are the linear and quadratic survival constants for reference low-LET radiation, and a and b refer to the survival constants for any LET. The value of a 0 /a R is the fraction of lethal lesions that form from a single PLL at the low LET reference radiation. Likewise, 1 -a 0 /a R is the fraction that forms from binary combination of PLL. The value of a 0 /a R is determined from the zero LET intercept of the relation of RBE 1P (y D ). It is between zero and one and closer to zero than to one for most mammalian cells as shown in Fig. 2 .
As illustrated in Fig. 2 , the inferred increase in RBE 1 with increasing LET is linear for LET less than about 50 keV/lm. This implies, per Eq. with an average value of 0.085 Gy À2 lm À2 .
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As LET exceeds about 50 keV/lm, the distribution of lethal lesions begins to deviate from the Poisson and, as illustrated in Fig. 2 , the value of RBE 1 reaches a cell-and particle-specific maximum and then begins to decrease. The peak in the value of RBE 1 occurs at an LET~100 keV/lm for protons ( 1 H + ), deuterons ( 2 H + ), and helium ( 4 He 2+ ) ions. Assuming that the deviation of RBE 1 from RBE 1P is due to increasing deviation from the Poisson distribution, the relation of RBE 1 to LET can be generalized to extend to LET greater than 50 keV/lm by multiplying RBE 1P by a saturation correction, 48 that is,
Here, r is a cross-sectional area related to the intersection of the trajectory of the high-energy ion as it passes through the distributed chromatin within the nucleus. 48 The decimal constant 0.14 has units such that if a R is in units of Gy
À1
, y D is in keV/lm and r is in lm 2 , the bracketed quantity that appears in the exponential and in the denominator is dimensionless. The value of r is determined from a regression analysis of RBE 1 as a function of LET with RBE 1P computed using Eq. (5). Note as illustrated in Fig. 2 , RBE 1 converges to RBE 1P as the LET becomes less than about 25-50 keV/lm.
The value of the LET at the maximum of RBE 1 is determined from the zero value of the derivative of Eq. (6) with respect to y D , that is,
The maximum attained by RBE 1 is determined by substitution of Eq. (7) into Eq. (6):
The value of r is dependent on details of nuclear size and shape, the distribution of chromatin and the orientation of the nucleus to the direction of the radiation beam. These features are challenging to control in laboratory studies and in vivo. As a result, the accuracy of experimental determinations of RBE 1 near its maximum is much less than for LET values less than about 50 keV/lm. There is no significant dependence on r, or the nuclear features that determine its value when LET is less than about 50 keV/lm. The estimated value of r for four mammalian cell lines ranges from 18 to 100 lm 2 with average equal to 50.75 lm 2 and ffiffiffi r p ranges from 4.2 to 10 lm with average equal to 7.12 lm (Hawkins 2003 (Hawkins , 2009 ). This implies assignment of a value of r for a specific clinical situation will be uncertain. Equations (7) and (8) set an upper limit for the value of RBE 1 and display the cell parameters that must be estimated to calculate RBE 1 for LET greater than about 50 keV/lm.
Note that Eqs. (5) and (8) indicate that the rate of increase in RBE 1P with LET and RBE max 1 are both inversely proportional to the radiosensitivity of the cell as determined by a R and (a/b) R . That is, as LET increases, the RBE 1P for a radiosensitive cell (large a R and constant b R ) increases less than the value of RBE 1P for radioresistant cell (small a R and constant b R ). Consequently, the ratio of a values for cells with different a R converges toward the same value as LET increases toward y max D . In general, cells irradiated by high LET ions tend to have a more equal radiation sensitivity (similar values of a) than do cells exposed to low-LET radiations. 97 Values of (a/b) R for an array of normal tissue and malignant cell populations have been measured and tabulated. 35, [67] [68] [69] [70] [71] [72] [73] Because of the limited range of values of the domain diameter, RBE 1 can be estimated with some degree of confidence from Eq. (5) for LET up to about 50-75 keV/ lm, using an average value of d equal 0.70 lm, and a value of the (a/b) R ratio appropriate to the irradiated population of interest. Because of dependence on r, calculation of RBE 1 becomes more uncertain as the LET becomes greater than 50-75 keV/lm. Table II summarizes the default and input parameters that need to be specified to perform RBE calculations using the MK model.
RMF Model
The RMF model 52 explicitly links the induction and biological processing of initial DSB to the formation of lethal point mutations and chromosome aberrations. In the RMF model, a coupled system of nonlinear ordinary differential equations is used to model the time-dependent kinetics of DSB induction, rejoining, and pairwise DSB interaction to form lethal (and nonlethal) chromosome damage. The RMF model assumes that it is the formation of lethal point mutations (e.g., fixation or misrepair of individual DSB) and chromosome damage (primarily exchanges) rather than the initial DSB or complexity that are the dominant mechanism underlying the effects of particle LET on reproductive cell survival. The RMF model postulates a first-order repair term that gives rise to exponential rejoining kinetics for most DSB (> 98%) and a second-order (quadratic) term to account for the small subset of the initial DSB (<2%) that undergo pairwise DSB interactions to form an exchange. The earlier lethal and potentially lethal (LPL) and repair-misrepair (RMR) models of Curtis 94 and Tobias 8 also postulate linear and quadratic terms for the repair of sublethal and potentially lethal damage. However, the RMF model treats initial DSB formation as a compound Poisson process, whereas DSB induction is effectively governed by a simple Poisson process in the earlier LPL and RMR models. A Poisson model for DSB induction is reasonable for low-LET radiation, but a poor approximation for intermediate-and high-LET radiation. 19, 52, 98 The RMF model considers the entire cell nucleus as the largest plausible volume for pairwise DSB interactions. The need for explicit subnuclear domains or sites is largely eliminated from the RMF model by considering pairwise DSB interactions arising from the same particle track (intratrack pairwise DSB interactions) separate from pairwise DSB interactions arising from two or more independent particle tracks (inter-track pairwise DSB interactions). For low-dose rates and/or for doses comparable to and smaller than a/b, the RMF system of differential equations is well approximated by the LQ cell survival model. 52 In the LQ approximation of the RMF model, a and b for a high-LET radiation are related to RBE DSB and the reference radiation LQ parameters (a R and b R ) by
In Eq. (9), the frequency-mean specific energy 74 where d is the diameter of the cell nucleus and q is the mass density of the cell nucleus. As indicated by Eq. (9), the radiation response characteristics of a cell exposed to a low-or high-LET radiation (a ion and b ion ) are uniquely determined in the RMF model by one dosimetric parameter ( z F ) that depends on LET (or lineal energy), a biological parameter (RBE DSB ) that depends on particle type and kinetic energy (and thus LET or lineal energy) but is largely the same among all eukaryotes in vitro and in vivo, and by the cell-, tumor-or tissue-specific parameters a R and (a/b) R . In the RMF model, the value of a R and (a/b) R reflect a cell's repair capacity as well as the subsequent survival response to misrepaired or unrepaired DNA damage formed by a low-LET reference radiation.
Upon substitution of RMF-based formulas for the ratios a ion /a R and b ion /b R [i.e., Eq. (9)], the RBE LD and RBE HD in Eq. (1) become
The terms in Eqs. (9) and (10) proportional to z F Á RBE DSB Á RBE DSB arises from the interactions of pairs of DSB formed by the same track ("intra-track pairwise DSB interactions"), and the term proportional to RBE DSB arises from the misrepair or fixation of individual DSB. Because of inter-track DSB interactions, b increases as the square of the RBE for DSB induction. For the special case when 2 z F RBE DSB =ða=bÞ R ( 1 , the low-dose and high-dose RBE are equal to the RBE DSB (i.e., RBE LD = RBE HD = RBE DSB ). Streitmatter et al. 54 provides evidence in support of the hypothesis that RBE LD ffi RBE HD ffi RBE DSB in representative mammalian cells irradiated by electrons and photons with a wide range of kinetic energies. For protons with kinetic energies greater than about 30 MeV and less than about 100-200 keV, the RMF model also predicts that RBE LD ffi RBE HD ffi RBE DSB because z F ( 1 Gy. For ions with Z > 2, intra-track DSB interactions have a significant impact on RMF estimates of a ion and, therefore, RBE LD ≥ RBE HD = RBE DSB .
To minimize the number of ad hoc adjustable parameters, RBE DSB is typically computed as a function of particle type, kinetic energy and oxygen concentration using the independently developed and tested MCDS software. 16, 17, 54, [62] [63] [64] [65] [66] Other Monte Carlo models [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] or measurements could also potentially be used to estimate RBE DSB . At present, the MCDS is the only Monte Carlo model for DNA damage induction with the ability to simulate the interplay between particle LET and oxygen effects. 16, 17, 66 Table III summarizes the parameters used in the MCDS to simulate the induction of DSB (and other types of damage) by ionizing radiation. The additional parameters required by the RMF model to predict particle RBE are also summarized in Table III. Calibration of the RMF for modeling the radiation response of a specific cell line, tumor or tissue mainly requires the determination of a value, or distribution of values, for a R and (a/b) R . Other parameters (RBE DSB and z F ) are computed from Monte Carlo simulations or measurements. Implicit in the determination of z F is the potentially cell-specific diameter of the nucleus. For most mammalian cell lines, the effective diameter d of the cell nucleus that gives the best fits to cell survival data usually falls within the range from about 2 to 5 lm; however, a representative value of d = 4 lm often suffices. It is important to note that estimates of a for low-LET radiations are insensitive to the value of d because 2 z F RBE DSB =ða=bÞ R is usually small compared to unity 54 . For a 200 MeV proton (LET = 0.451 keV/lm) and (a/b) R = 1 Gy, RBE DSB = 1.0 and z F ¼ 4 Â 10 À3 (d = 5 lm); therefore, 2 z F RBE DSB =ða=bÞ R ¼ 0:007 ( 1. The RMF model for a becomes even less sensitive to the selection of a value of d as the value of (a/b) R increases.
Appropriate cell-specific values for a R and (a/b) R can be determined using two fundamentally different calibration procedures. The first calibration method determines values for a R and (a/b) R from a nonlinear regression analysis of measured cell survival data for a low-LET reference radiation. 11, 52, 54 The second calibration method determines values for a R and (a/b) R from a nonlinear regression analysis of measured cell survival data for a low-LET reference radiation and one or more additional, higher LET radiation. The first method often suffices, but the second method is sometimes advantageous when analyzing small datasets with large uncertainties in the dosimetry and plating efficiency underlying measurements of reproductive cell survival. Both calibration methods are illustrated in Fig. 3 .
The lower left and right panels of Fig. 3 show comparisons of measured [111] [112] [113] [114] [115] and RMF estimates of the surviving fraction for 200-250 kV x rays (reference radiation) and selected 4 He ions with an LET up to 90.3 keV/lm. In this analysis, the cell-specific values for a R and (a/b) R are obtained from an LQ analysis of the human kidney T1 cell survival data for the reference radiation only (solid line in the lower panel of Fig. 3 ), that is, the first calibration method was used. The dashed lines in the lower and left and right panels of Fig. 3 are RMF predictions (no fitting to the measured data) based on the estimates a R and (a/b) R for cells irradiated by kV x rays under aerobic conditions and then using the MCDS to estimate z F (nucleus diameter of 4 lm) and RBE DSB as a function of particle type, kinetic energy and oxygen concentration (left panel: cells irradiated under aerobic conditions; right panel: cells irradiated under anoxic conditions).
The upper left panel of Fig. 3 shows a simultaneous fit of the RMF model to the measured V79 cell survival data protons ( 1 H + ) and helium ( 4 He 2+ ) ions (second calibration method). In the fit to the measured cell survival data, the MCDS was used to compute the energy-and ion-specific value for z F (nucleus diameter of 5 lm) and RBE DSB . The cell-specific value for a R and (a/b) R was determined by minimizing the squared difference (residual) of the logarithm of the measured and RMF-predicted surviving fraction. The upper right panel of Fig. 3 shows the family of all combinations of a and b that fit the measured data about equally well, that is, the filled symbols show the results of a bootstrap simulation to determine the confidence intervals on a and b.
69,116
The right panel of Fig. 3 also is also an illustration of the large uncertainties in radiation response parameters a R and b R [and hence (a/b) R ] even for well characterized cell lines.
QUANTITATIVE COMPARISONS OF PARTICLE RBE
The LEM IV and RMF model explicitly link the RBE for reproductive cell survival to the induction and biological processing of radiation-induced DSB. In contrast, the MK model parameterizes cell survival in a way that emphasizes subcellular dosimetry ("microdosimetry") and largely dispenses with the need for explicit modeling of DSB induction or any other specific type of DNA damage. Conceptually, the MK model is instead developed in terms of a general category of potentially lethal lesion (PLL) that sometimes become lethal as they interact and accumulate within subnucleus domains. To the extent that PLL are synonymous with DSB induction, the MK model can be considered an alternate formalism to link the induction and repair of DSB to reproductive cell survival. Others 117, 118 have taken a more explicit approach toward modeling DSB induction within the framework of the MK model.
As a way to highlight the quantitative similarities and differences among mechanism-inspired RBE models, Fig. 4 compares, for a wide range of particle types and energies, estimates of DSB induction. Then, Figs. 5, 6 and 7 examine key model parameters (e.g., ratio of a parameters for a particle of interest to the value of a for a reference radiation) and the RBE for cell survival for clinically relevant particle doses of~1 Gy ( 4 He and 12 C ions) to 1.8 Gy ( 1 H ions; 1.8 Gy protons correspond to 2 Gy MV x rays using an RBE of 1.1) as well as a large dose per fraction scenario of 10 Gy (hypofractionated particle treatment). The intercomparison of model results are based on a reference radiation (a/b) = 2 or 10 Gy. Other LEM IV, RMF, and MK model parameters were selected a priori to be representative of human cells. It is important to note that the default values for some model inputs in one model differ from the default value used for the same (or almost the same) quantity in other models (refer to  Tables I-III) . It is important to acknowledge in that perspective that many biological parameters, even the diameter of the cell nucleus, are highly uncertain when taken as a representative (default) value for a specific cell line, experiment, tissue, or tumor. As illustrated in the upper right panel of Fig. 3 , there are typically many combinations of a and b (or a/b) that fit the results of measurements about equally well. Figure 4 compares the predicted RBE for DSB induction as a function of (Z eff /b) 2 (left panel) and as a function of unrestricted LET (right panel) in the LEM IV 45, 46, 119 and MCDS. 16, 17, [64] [65] [66] As a first approximation, the MK model is premised on the idea that the RBE for induction of potentially lethal DSB is approximately equal to unity, regardless of (Z eff /b) 2 , as illustrated by the red dotted line in the left and right panels of Fig. 4 .
3.A. Comparison of the RBE DSB
In the left panel of Fig. 4 , trends in DSB induction are plotted against the squared ratio of the effective charge on the ion divided by the speed of the particle (Z eff /b) 2 , rather than LET. The main advantage of using (Z eff /b) 2 rather than LET for the presentation of RBE data is that particles with the same (Z eff /b) 2 have approximately the same collisional stopping power (~LET) regardless of particle type or kinetic energy, whereas particles with the same LET can correspond to very different kinetic energies and biological effects. For example, a 4 and 900 keV 1 H ions both have an LET of about 28 keV/lm, but a (Z eff /b) 2 of 10,970 and 518, respectively. On the basis of LET, one would expect these ions to be equally damaging in terms of molecular and cellular endpoints; in terms of (Z eff /b) 2 , the low-energy (4 keV) 1 H ion is about 70% more effective at creating DSB, per unit absorbed dose than the higher energy (900 keV) 1 H ion. Estimates of RBE DSB are shown as a function of LET in the right panel of Fig. 4 for ions with a continuous slowing down approximation (CSDA) range of 0.05 mm (50 lm or about 5 cell diameters). As the range of the ion becomes comparable to the dimensions of one or a few cell diameters, the geometric model of the target (cell, cell nucleus, chromatin, and DNA) as well as end-of-range-effects (e.g., energy and pathlength straggling) can become significant, 17 leading to substantial uncertainties in experimental data as well as model predictions.
As illustrated in the left panel of Fig. 4 , the relative numbers of DSB per unit absorbed dose in the LEM IV and MCDS exhibit the same general trend toward a substantial increase in RBE DSB with increasing (Z eff /b) 2 up to (Z eff / b) 2 =~1000; however, the LEM IV values for RBE DSB are systematically lower than the values predicted by the MCDS in this region. For values of (Z eff /b) 2 greater than~2,000, the value of RBE DSB from the LEM IV rapidly increases with increasing (Z eff /b) 2 up to 10,000. In strong contrast, estimates of RBE DSB from the MCDS increase in a monotonic fashion with increasing (Z eff /b) 2 and approach an asymptotic value of 3.4 for values of (Z eff /b) 2 greater than about 10,000. As illustrated in the right panel of Fig. 4 , the LEM IV predicts a more pronounced dependence of RBE DSB on the ion species than the MCDS. For very high-LET radiations, the LEM IV predicts much larger values for RBE DSB than the MCDS. The general trends in RBE DSB from the MCDS are in excellent agreement (~5%) with results from track structure simulations, 17, [64] [65] [66] which is largely due to the fact that several parameters (Table III) used in the MCDS (r Sb , N min , u,v,w) have largely been determined from fits 64, 65 to these data. Other parameters (f, M 0 , K, q, and r) are taken from the literature or based on fits to measured data. 66 However, the MCDS asymptotic value of~3.4 for very large LET and (Z eff /b) 2 values is larger than the asymptotic value of~2 to 2.5 from track Stewart et al.: Mechanistic particle RBE models e937 structure simulations. The~30-35% difference in the asymptotic value of RBE DSB can be attributed to differences between the methods used to group individual lesions into DSB 120 and to the geometric model of the cell and cell nucleus. 17 For a low-LET reference radiation, such as 60 Co c rays, the number of DSB Gy À1 cell À1 is related to RBE DSB by N bp RBE DSB R R , where N bp is the number of base pair (bp) of DNA per cell and Σ R is the number of DSB Gy À1 Gbp
À1
for the reference radiation. In the MCDS, Σ R = 8.3 Gy À1 Gbp À1 for 60 Co c rays and 5.0 Gy À1 Gbp
in the LEM IV. For a diploid human cell with N bp = 6 Gbp, the MCDS predicts~50 DSB Gy À1 cell À1 for 60 Co c rays compared to~30 DSB Gy À1 cell À1 in LEM IV. For comparison to the 1.7-fold difference in the absolute number of DSB Gy À1 cell À1 between the models for 60 Co c rays (50 in the MCDS and 30 in LEM IV), the relative number of DSB varies by 5-15% for 1 H + ions, by up to 30% for 4 He ions, and by as much as 60% for 12 C ions with a CSDA range greater than 0.05 mm. The results shown in Fig. 4 clearly demonstrate that the relative and absolute numbers of numbers DSB Gy À1 cell À1 (or Gbp À1 ) substantially differ in the MCDS and LEM IV depending on the LET and (Z eff /b) 2 . 
3.B. Comparisons of the RBE for cell survival
Figures 5-7 show comparisons of key ratios of parameters (a ion /a R ) in the upper left panels and square root of b ion /b in the upper right panels and estimates of the RBE for cell survival (lower left and right panels) from the LEM IV, RMF, and MK models for 1 H, 4 He, and 12 C ions, respectively. In all three models, the ratio of a ion /a R corresponds to the RBE for cell survival in the limit as the dose becomes very small compared to the (a/b) R , that is, RBE LD in Eq. (1). In the terminology of the MK model, RBE LD = RBE 1P for lower LET ions (less than about 50 keV/lm) and RBE 1 for higher LET ions (greater than about 50 keV/lm). In the MK and RMF models, the ratio (b ion /b c ) 1/2 is the RBE for cell survival in the limit as the dose becomes very large compared to (a/b) R , that is, RBE HD = (b ion /b c ) 1/2 . In the RMF model, the ratio (b ion / b c ) 1/2 is exactly equal to RBE DSB because the kinetics of the binary misrepair process are considered independent of dose. In the LEM IV, RBE HD is determined by the final (linear) slopes of the survival curves for the ion and reference radiation, that is, RBE HD = (a ion + 2b ion D t )/(a R + 2b R D t ) for doses larger than D t . 44, 86, 121 The results shown in Figs. 5-7 are restricted to particle kinetic energies in which the CSDA range of the ion is >0.05 mm (50 lm or about 5 cell diameters) to avoid the challenges associated with modeling the fine details of the cellular and subcellular targets as well as track-end effects, such as energy and pathlength straggling. Except where noted otherwise, the RBE estimates shown in Figs. 5-7 are based on the following representative model inputs:
3.B.1. LEM IV
Predictions of the RBE were performed for a R = 0.076 and 0.38 Gy À1 as well as b R = 0.038 Gy À2 for (a/b) R = 2 and 10 Gy, respectively, in accordance with input values selected for the MK model (see below). The threshold dose D t of the LQL model was calculated by an empirical formula using the selected value of (a/b) R. 46 The cell diameter was set to 10 lm in agreement to typical human non-fibroblast cell line. . For a known value of (a/b) R , the value of a 0/ a R (range 0-1) is determined by Eq. (5) in the limit as RBE 1P approaches unity. Values of a 0/ a R close to unity occur in radiosensitive cells in which PLL produced by individual tracks are unrepairable and lethal. As LET increases beyond about 50 keV/lm and the distribution of lethal lesions no longer adheres to a Poisson distribution, and RBE 1 is computed using Eq. (6) with r = 63 lm 2 , that is, the average value of r reported in Ref. [48, 97] for six common cell lines.
3.B.2. MK model

3.B.3. RMF model
RBE estimates are all based on estimates of z F and RBE DSB as a function of particle type and kinetic energy from MCDS simulations for a representative cell nucleus 4 lm in diameter that is uniformly irradiated by monoenergetic charged particles. As evident through an examination of Eqs. (1) and (10), the only other parameter required to determine the RBE for cell survival as a function of dose D is the reference radiation value for (a/b) R .
As illustrated in the upper left panel and lower left and right panels of Figs. 5-7, the ratio of (a ion /a R ) and the RBE for cell survival tends to decrease with increasing (a/b) R in all three models. All three models also predict a general trend toward a smaller RBE for cell survival with increasing dose (e.g., compare the lower left and right panels of Figs. 5-7) . The LEM IV, RMF, and MK models all predict a general trend toward a monotonic increase in (a ion /a R ) and in the RBE for cell survival with increasing LET. For protons (Fig. 5) , (a ion /a R ) and the RBE for cell survival is approximately a linear function of LET. For 4 He ions (Fig. 6) , (a ion / a R ) and the RBE for cell survival is a nonlinear (closer to a linear-quadratic) function of LET. For 12 C ions (Fig. 7) , the LEM IV and MK model predict that (a ion /a R ) and the RBE for cell survival increases with increasing LET up to a peak in the range from 150 to 250 keV/lm and then begins to decrease with increasing LET. In the RMF model, the RBE for cell survival increases in a linear-quadratic fashion with increasing LET and does not show a decrease at high LET values in the 2008 implementation of the RMF model. In general, the trends and absolute magnitude in the RBE for cell survival are most similar among the LEM IV, MK, and MCDS + RMF models for 1 H and 4 He ions (Figs. 5 and 6). For carbon ions, the general trends in the RBE for cell survival are similar in the LEM IV and MK model, and quite different from the trends predicted by the MCDS + RMF system of models (Fig. 7) . There is as much as a twofold difference in the lower dose RBE for cell survival (lower left panel of Fig. 7 ) among all three models for carbon ions with an LET less than about 300 keV/lm. A 300 keV/lm carbon ion has a kinetic energy~50 MeV, a CSDA range~0.1 mm, and (Z eff /b) 2 = 3825. For low doses of carbon ions with an LET > 300 keV/lm, the MCDS and RMF system of models predicts as much as a threefold higher RBE for cell survival than the LEM IV or MK model. For large doses of carbon ions and an LET greater than about 100 keV/lm, the MCDS + RMF system of models also predicts a substantially larger RBE for cell survival than the LEM IV or MK model. A 100 keV/lm carbon ion has a kinetic energy~200 MeV, CSDA range~1 mm and (Z eff /b) 2 < 3825. The differences in low-dose and high-dose carbon ion RBE are most significant for short range (low energy, high LET) carbon ions, that is, near the tip of a pristine Bragg peak and beyond. For highenergy carbon ions (LET less than 100 keV/lm) proximal to the tip of the Bragg peak, these differential effects are much less significant (Fig. 7 lower left and right panels) .
For protons, estimates of the RBE for cell survival are relatively insensitive to the value of (a/b) R in the RMF model, regardless of the dose. As illustrated in lower panels of Figs. 6 and 7, the RMF model predicts that the RBE for cell survival becomes more sensitive to the value of (a/b) R with increasing atomic number (particle mass). In the LEM IV and MK model, the RBE for cell survival is sensitive to the value of (a/b) R for small proton doses (lower left panel of Fig. 5 ) and less sensitive to (a/b) R for large proton doses (lower right panel of Fig. 5 ). In the LEM IV, estimates of the RBE for cell survival become less sensitive to the value of (a/b) with increasing atomic number (lower panels of Figs. 6 and 7 ). The MK model predicts that the RBE for cell survival is sensitive to the value of (a/b) R for small doses (lower left panels of Figs. 5-7) , regardless of the type of ion, and much less sensitive to the value of (a/b) R for large doses (lower right panels of Figs. 5-7) .
One of the more striking differences among the LEM IV, RMF, and MK models are the general trends in the ratio (b ion /b R ) 1/2 with particle type and LET shown in the upper right panels of Figs. 5-7. The MCDS + RMF system of models predicts that the ratio of (b ion /b R ) 1 1/2 arise in the RMF model because this ratio represents the RBE for cell survival in the limit as the dose becomes large compared to (a/b) R , that is, RBE HD in Eqs. (1) and (10) . In this limit, the RMF model predicts that RBE HD = RBE DSB because the pairwise interaction of DSB formed by different particle tracks dominates the formation of lethal chromosome aberrations and the kinetics of this binary misrepair process are considered independent of the number of DSB present in the cell. In contrast to mechanism-inspired trend in (b ion /b R ) 1/2 within the RMF model, analyses of cell survival data using the MK model have found that (b ion /b R ) 1/2 = 1 suffices for both low-and high-LET radiations (blue dotted lines in the upper right panel of Figs. 5-7 ). In the LEM IV, the ratio of (b ion /b R ) 1/2 decreases with increasing LET. 35 Also, it is important to note that the LEM IV transitions from a simple LQ dose-response to a LQL type of response with a final linear slope of s max = (a + 2bD t ) for doses greater than or equal to D t . 44, 86, 121 The LEM IV, MK, and RMF models embody very contradictory trends in the ratio of (b ion /b R ) 1/2 with increasing LET, that is, (b ion /b R ) 1/2 decreasing with increasing LET in the LEM IV, is a constant independent of particle type and LET in the MK model, and increases with increasing LET in the RMF model when the MCDS is used to determine RBE DSB .
Over the dose ranges used in nearly all in vitro cell survival experiments, very high-LET radiations often exhibit a close to linear dependence on dose, that is, S(D) ffi exp(ÀaD) for high-LET radiations compared to S(D) ffi exp(ÀaD À bD 2 ) for low-LET radiations. A linear cell survival response with dose implies that either (a) b ion decreases with increasing LET or (b) the dose range is small compared to (a/b) ion . In this latter scenario, the measured data do not provide sufficient information to show that b ion is decreasing rather than constant (MK model) or increasing with increasing LET (RMF model using the MCDS to predict RBE DSB ). As illustrated in the upper right panel of 
CONCEPTUAL AND COMPUTATIONAL DIFFERENCES IN THE LEM IV, MK, AND RMF MODELS
The most significant characteristics of the LEM IV, MK, and RMF models are summarized and compared in A refinement to the Carlson et al. 52 version of the RMF model that includes overkill effects is proposed in Butkus et al. 138 With this refinement, a ion and b ion increase with increasing LET up to a ion-specific peak and then decrease.
Table IV. For the endpoint of reproductive cell survival, the mechanisms underlying particle RBE as considered in the LEM IV, MK, and RMF models arise on three distinct spatial scales, namely on the few nm scale, the 0.5-1 lm scale, and the~5 lm scale. However, the mechanisms of action operating on these spatial scales are not explicitly modeled to the same level of detail or at all in some cases. Some of the most relevant parameters and the corresponding spatial scales associated with various mechanisms of action are indicated in Table IV . As indicated and discussed in more detail below, similar scales in different models might also be attributed to different mechanisms. Therefore, all three models implicitly or explicitly account for the stochastic and spatial aspects of the induction and biological processing of initial DSB/PLL into more lethal forms of damage (mostly chromosome aberrations) in varying levels of detail. The MK and RMF models exploit probability theory to develop simple analytic RBE formulas [Eqs. (5), (6), (9), and (10)], whereas the LEM IV model uses a multiscale combination of deterministic and Monte Carlo methods to compute particle RBE.
The rest of this section uses Table IV as a guide to organize and discuss overall model characteristics and putative mechanisms of action in more detail. The conceptual comparison focuses on (a) the types of initial DNA damage, (b) the spatial distribution of DNA damage along individual tracks and among cells, the mechanisms and length scales considered most relevant for the calculation of particle RBE [i.e., (c) lesion interaction and (d) lesion saturation], and (e) the effective trends in relative effectiveness of an ion relative to a low-LET reference radiation. Additional details and parameters used in all three models are summarized in Tables I-III . Because the RMF model requires as an input the relative DSB yield as a function of particle type and kinetic energy to compute the RBE for cell survival (e.g., from an auxiliary Monte Carlo model or experimental data), conceptual details of the MCDS are also discussed in this subsection and in Table IV .
4.A. Initial DNA damage
In all three models, DSB are considered the most critical type of initial damage governing a cell's reproductive fate. The MK model is formulated and usually discussed in terms of a general class of PLL (potentially lethal lesion). Ionizing radiation is assumed to cause two types of lesion in the DNA of the cell. A type I lesion is lethal to the cell and is not repairable. A type II lesion, or PLL, may undergo one of four transformations. The LEM IV considers two different types of DSB: An iDSB is formed when a single DSB is created in a chromatin loop, and a cDSB is created when two or more DSB are formed in a chromatin loop. The clustering of two or more DSB within a chromatin loop to form a cDSB is a central mechanism of DSB interaction in the LEM IV, as discussed in more detail in the next subsection. The track structure model included as part of the LEM IV is used to predict the absolute and relative numbers of individual DSB as a function of particle type and kinetic energy (e.g., see Fig. 4) . The dose along a track is determined by the stopping power of the ion in water and four track structure parameters (c, d, r c , and r), as summarized in Table I . The relative and absolute number of DSB Gy À1 cell À1 are determined by the a DSB , a SSB , and h parameters (Table I) . On the smallest (~25 bp) spatial scale, the LEM IV accounts for the clustering (interaction) of individual single-strand breaks to form a DSB as a consequence of inter-track effects between different secondary electrons emitted by the same primary ion; this interaction is controlled by the h parameter in the LEM IV.
As emphasized by Eqs. (9) and (10), the RMF model predicts that the RBE for cell survival only depends on the z F ; ða=bÞ R and the relative number of DSB per unit absorbed dose (i.e., RBE DSB ). In the RMF model, the absolute number of DSB per unit absorbed dose, or per track is irrelevant for modeling of particle RBE. The RMF model relies on measurements or an auxiliary model to compute RBE DSB as a function of particle type and kinetic energy. The RMF results shown in Figs. 5-7 were computed using the MCDS. The data shown in Fig. 3 provide evidence that the MCDS suffices for the determination of RBE DSB when modeling cell survival in the RMF model for Z < 2 ions with an LET less than about 150-200 keV/lm. One of the more useful aspects of the MCDS is that it is the only Monte Carlo model currently available to simulate the effects of oxygen concentration on DSB induction. 16, 17, 54, 66 As illustrated in the lower right panel of Fig. 3 , the survival response of cells irradiated under anoxic conditions can be predicted using the RMF model with reasonable accuracy from the survival response of cells irradiated under normoxic conditions (lower left panel of Fig. 3 ) when the MCDS is used to recompute the ion-specific value for RBE DSB under anoxic conditions.
One of the more unusual aspects of the MCDS is that the effects of track structure on DSB induction (and other types of DNA damage) are simulated at the nanometer scale (level of a few tens of bp) without any need for charge particle stopping powers or a model for the 3D spatial distribution of energy deposits along a particle track. In lieu of the track structure approach, the MCDS randomly inserts r sb individual strand breaks and fÁr sb sites of base damage into a small section of DNA that varies with (Z eff /b) 2 (n seg in Table III ). The random insertion of individual strand breaks or base damage into a short segment of DNA is conceptually similar to a stochastic biophysical process in which randomly formed energy deposits intersect with a nanometer-sized volume of the cell nucleus and randomly create individual strand breaks or base damage. The tendency toward increasing numbers of DSB and decreasing numbers of non-DSB clusters, including SSB, as the particle LET increases arises in the MCDS because the number of lesions per unit length of DNA increases with increasing LET, that is, r Sb and f are constant and n seg decreases with increasing LET. As shown in Table III , several additional parameters are used in the MCDS to group individual DNA lesions into clusters (N min parameter) and to simulate the chemical repair and oxygen fixation (M 0 , K, q, and r parameters) process. 66 In the MCDS, the four track structure parameters (c, d, r c , and r) and the interaction parameter h~25 bp used in the LEM IV are effectively replaced by the N min~9 bp parameter and the three additional parameters (u,v,w) implicit in the specification of the chromosome segments used in the MCDS, that is, the n seg (u,v,w) parameter which decreases 149.2 to 25.9 kbp with increasing (Z eff /b) 2 . Similarly, the a SSB , a DSB parameters in the LEM IV are replaced by the r sb parameter in the MCDS. The MCDS parameter f, which determines the ratio of base damage to strand breaks, has a negligible impact on determinations of the number of DSB Gy À1 Gbp À1 ; it is most relevant for determinations of the number of non-DSB clusters Gy À1 Gbp
À1
, including the number of SSB Gy À1 Gbp
.
4.B. Spatial distribution of initial DSB/PLL
Ionization density, as quantified by one-dimensional metrics (LET and y D ) or through a full 3D track structure simulation, give rise to some of the most significant differences in the biological effectiveness of low-and high-LET radiations. On a nanometer scale (one or two turns of the DNA up tõ 50-100 bp), differences in ionization density gives rise to changes in the local complexity of potentially lethal DSB as well as potential changes in the relative number of DSB, as illustrated in Fig. 4 . On the larger scale, the distribution (density) of potentially lethal DSB along individual particle tracks has a significant impact on the RBE for cell survival in all three models, although implemented in a different way. For very high-LET radiation types in which the mean-specific energy ( z F ) becomes comparable to the absorbed dose, the DSB distribution among a group of uniformly irradiated cells is poorly approximated by a Poisson distribution. 19, 44, 48, 52, 98 A non-Poisson distribution of initial DSB (or PLL in the MK model) gives rise to so-called over-and underdispersion effects in the formation of chromosome aberrations and lethal damage. 122, 123 The conceptual and computational approaches taken in the LEM IV, MK, and RMF to model the density of potentially lethal DSB along individual tracks and among cells differ significantly but are nevertheless comparable in many ways, for example, the RBE for cell survival initially tends to increase in monotonic fashion with increasing LET.
The LEM IV primarily attributes the reproductive fate of a cell to the local spatial distribution (density) of initial DSB and their mutual proximity within the cell nucleus. 45 The LEM IV uses an amorphous track structure model to determine the 3D distribution of DSB along an ion's direction of flight and among cells. The high local dose within the center of a particle track creates individual strand breaks that combine (h = 25 bp parameter) to form additional DSB that increase RBE DSB and the number of DSB within a chromatin loop (~2 Mbp in length). In the LEM IV, chromatin loops are represented by a cubic region of the nucleus with a side of length~0.5 lm (l loop parameter). Representative human cells contain~3000 individual loops. As a measure of DSB clustering at the chromatin level (~0.5 lm) and among cells, the number of iDSB (loops with a single DSB) and cDSB (loops with two or more DSB) are counted and used to compute a cluster index C defined by Eq. (2). This cluster index is then used to determine equivalent doses of the reference radiation and ion of interest. An attractive aspect of the LEM IV is that the initial spatial distribution of DSB arises from an explicit consideration of the full 3D spatial distribution on all relevant spatial scales, that is, from a few nanometers (~25 bp) up to the level of the cell nucleus (~5-10 lm). The LEM IV approach toward modeling the initial number and spatial distribution of DSB tends to minimize the number of ad hoc adjustable parameters (Table I) , but somewhat increases the overall computational complexity of the model.
In contrast to the explicit 3D simulation of DSB distributions in the LEM, the MK, and the RMF models use probability theory to describe the distribution of initial potentially lethal DSB along individual tracks (i.e., proportional to LET or y D ) and among cells. Systems of differential equations are then used to model the temporal evolution (kinetics) of various processes that give rise to lethal damage, mostly various types of lethal chromosome aberrations. The discussion here is restricted to solutions of these equations for the case of acute irradiations at sufficiently long time intervals afterwards such that all repair, misrepair, and fixation processes are complete. In the RMF model, the density of DSB along a one-dimensional track (i.e., no radial extent) is proportional to z F Á RBE DSB , and the average distance between DSB along the trajectory of an ion is proportional to d= z F Á RBE DSB 16 . Here, z F / y D ffi LET is the frequency-mean specific energy. 74 Because of the trend toward increasing numbers of DSB per track with increasing LET, the probability that a pair of DSB interacts to form a lethal chromosome aberration also increases. While such an increase in the number of DSB per track implies an increase in the DSB density, and thus, a decrease in the mean distance between DSB, the RMF predicted increase in lethality arises from the stochastic distribution of DSB along a track and among cells (i.e., the use of a compound Poisson distribution for initial DSB induction) rather than from the spatial proximity of two or more DSB, as in the LEM IV and MK model. The use of a compound Poisson distribution to separate lethal damage formed through the intra-and inter-track binary misrepair is one of the hallmarks of the RMF model.
In the MK model, the average number of PLL per unit absorbed dose is independent of LET as a first approximation (i.e., RBE PLL ffi 1). However, the per track number of PLL is proportional to y D or, as a first approximation, proportional to particle LET. The distribution of initial PLL along individual tracks and within subnuclear domains (MK model Tables II and IV) is effectively modeled as a Poisson distribution. For a uniformly irradiated region of tissue, the distribution of primary particle tracks through the cell nucleus is also governed by a Poisson distribution. 74 Therefore, the approach taken in the MK model is equivalent to the use of a compound Poisson distribution for initial DSB induction, as in the RMF model. 52 For low-LET radiations (e.g., <50 keV/lm), a compound Poisson distribution for the induction of PLL or DSB reduces to a Poisson distribution because the average number of potentially lethal DSB per track is small; hence, it is the Poisson distribution of primary tracks passing through a cell that determines the distribution of initial damage at the level of subnuclear domains and the cell nucleus. A key difference among the models is that the MK model treats RBE PLL ffi 1, whereas the LEM IV and MCDS predict a trend toward increasing numbers of potentially lethal DSB with increasing LET, as shown in Fig. 4 .
4.C. DSB and PLL interaction mechanisms
At the length scale of 0.5-1 lm, the interactions of DSB to form a lethal lesion are defined by the l loop (~2 Mbp and sites with a side length of 0.5 lm) parameter in the LEM IV and by the domain diameter d in the MK model (~0.4 to 0.7 lm). In the MK model, the subnuclear domain diameter defines a boundary that corresponds to the maximum distance in which pairs of PLL can interact to form a lethal lesion. The concept of a subnuclear domain in the MK model is conceptually similar to the sites defined in the TDRA. 92, 93 The site concept in the MK model is motivated by the analysis of radiation-induced chromosome aberrations and cell killing for low-and high-LET radiations. That is, the frequency of intra-and inter-track pairwise PLL interactions implicitly defines the target size associated with the formation of chromosome aberrations and cell killing as a function of particle LET.
Although having similar numerical values as the domains in the MK model, the 0.5 lm scale in the LEM IV is motivated by a specific structure in the chromatin organization, namely the so-called giant loops, having a DNA content of approximately 2 Mbp (l loop parameter). As in the MK model, the size of a chromatin loop is considered independent of the cell type by default (as noted in Table I ), although in reality the size of a chromatin loop is likely to vary and obey a certain distribution that might depend, for example, on the shapes and volume of the nucleus. However, the size of a loop of~2 Mbp is still presumably conserved. It is also worth noting that the size of chromatin loops approximately corresponds to the extension of the region around DSBs that is phosphorylated within the formation of cH2AX foci, 124, 125 and this may provide a direct measure of the iDSB and cDSB concepts used in the LEM IV. On the 0.5 lm spatial scale, the interactions among DSB are implicit in the classification into DSB as either an iDSB or a cDSB. No specific assumptions are made about physical or biological interactions of DSB to form lethal lesions (i.e., chromosome aberrations). It is merely assumed that cDSB are more challenging to repair and thus have a larger probability of lethality as compared to iDSB. The loss of DNA fragments in a chromatin loop is one of the processes that are more likely to occur in the case of cDSB as compared to iDSB and thus could lead to a correspondingly higher lethality. These assumptions are implicit in the calculation of a cluster index C [Eq. (2) ] and in the calculation of equivalent reference radiation and ion particle doses that produces the same cluster index [i.e., Eq. (3)].
In contrast to the subnuclear targets and domains considered in the LEM IV and MK models, DSB formed anywhere within a cell nucleus of diameter d (~2-5 lm) have the potential to interact in pairwise fashion to form lethal chromosome aberrations in the RMF model. In the RMF model, pairwise DSB interactions are subdivided into the interactions of DSB formed by the same particle track (intra-track DSB interactions) and the interactions of DSB formed by different particle tracks (inter-track DSB interactions). Conceptually, DSB formed by the same particle track tend to be created in closer spatial and temporal proximity to each other than DSB formed by different particle tracks. The trend toward increasing numbers of interactions with increasing DSB density (decreasing distance) is one of the central ideas motivating socalled proximity effects 126, 127 in the Breakage and Reunion Theory of chromosome aberration formation. 20, [128] [129] [130] [131] [132] One important difference between the RMF model and the LEM IV and MK models is the approaches taken toward modeling proximity effects. In the LEM IV and MK models, proximity effects arise when multiple instances of potentially lethal damage are formed within a specific subcellular target (chromatin loop or subcellular domain), regardless of whether the cluster of potential lethal damage arises from an individual or multiple particle tracks. In contrast, the RMF model does not specifically define or identify a subcellular target (or distance) over which pairs of DSB are more likely to interact; instead, high LET effects arise in the RMF model by modeling DSB induction using a compound Poisson distribution. The use of a compound Poisson distribution implicitly determines the density and spatial distribution of DSB within and among cells. That is, DSB formed along high LET particle tracks tend to be in closer spatial proximity than DSB formed by different particle tracks. In the RMF model, the density of DSB along a particle track is proportional to z F Á RBE DSB , and the average distance between DSB along the trajectory of an ion is proportional to d= z F Á RBE DSB (right panel of Fig. 2 in Ref. [16] ). In contrast to the LEM IV and MK models, it is the stochastic distribution of DSB formed along individual tracks and among cells that leads to enhanced cell killing rather than the spatial clustering and interaction of potentially lethal damage in specific subcellular targets. In practical terms, the RMF model has one less parameter than the LEM IV or MK model (i.e., a parameter equivalent to l loop in the LEM IV and domain diameter d in the MK model) at a potential cost of decreasing the ability of the RMF model to fit measured data. It is also worth noting that the l loop and d parameters are often assigned a default value independent of cell type in vitro and in vivo, as indicated in Table I (LEM IV) and II (MK model), respectively.
4.D. Saturation/overkill mechanisms
Above an ion-and LET-specific peak value, published studies 34, [133] [134] [135] [136] often indicate that radiation-induced cell killing decreases with increasing LET. This decrease in the RBE for very high-LET radiations can be traced back to deviations from a Poisson distribution of lethal damage. For LET values below approximately 150-200 keV/lm with an average of less than one lethal lesion per particle traversal, the distribution of lethal lesions among cells is well approximated by a Poisson distribution. For higher LET radiations, the distribution of lethal lesions becomes non-Poisson because individual particle tracks can infer multiple instances of lethal damage, and the ratio of the variance of the distribution to the mean of the distribution exceeds unity. 23, 137 The overkill or saturation effects that arise from the non-Poisson distribution of lethal damage is sometimes called an over-dispersion effect. The overkill or overdispersion effect has likewise been termed a damage saturation correction to emphasize that a further increase in damage within tracks does not further increase cell killing.
The lack of an overkill or saturation effect in the RMF model for high LET 12 C ions arises from the fact that deviations from the Poisson distribution of lethal damage are not yet taken into account. However, the RMF model can be easily extended to account for these forms of overkill effect by replacing RBE 1P in Eq. (6) 138 that, within the framework of the RMF model in combination with the MCDS, clustering of multiple DSB within a few tens of nanometers, a spatial proximity effect, is an alternative hypothesis to explain the overkill effects observed for Z > 2 ions with an LET beyond~150-200 keV/ lm.
In the LEM IV, there is another potential mechanism that may contribute to saturation effects, that is, situations in which more than 2 DSB are induced in the same loop. Because all loops with two or more DSB are categorized as a single cDSB, the additional DSB formed in a loop do not further increase cell killing. For a given total number of DSB induced per particle traversal, the regional cluster of multiple DSB in a chromatin loop to form a cDSB reduces the overall RBE. However, as this type of saturation mechanism only occurs for high-LET radiations, it is closely related to saturation effects arising from the creation of more than one lethal lesion per particle traversal; it might thus happen that loopwise saturation does not become apparent in the analysis because the total number of cDSB is sufficiently large to still represent more than one lethal lesion per traversal.
4.E. Overall trends in cell survival and LQ model parameters
In the reported comparisons of RBE shown in Figs. 5-7, the MK and RMF models rely on the LQ model for the representation of low-and high-LET cell survival response. In contrast, the LEM is based on a modified LQ model that transitions from a linear-quadratic dose-response for doses below D t to a linear dose-response shape for doses larger than D t . The parameter D t does not have a mechanistic interpretation and optimal, cell-specific values for D t are determined from an empirical relationship that has been deduced from a restricted set of in vitro experimental data. 35 As a first approximation, the same D t value is used for a given cell line, regardless of whether the radiation is a low LET or high LET type of radiation. In all three models, the RBE for cell survival in the limit as the dose becomes small compared to (a/ b) R is determined by the ratio (a ion /a R ) as seen in the upper left panel of Figs. 5-7. For the opposite extreme as the dose becomes large compared to (a/b) R , the RBE for cell survival approaches (b ion /b R ) 1/2 in the MK and RMF models. In the LEM IV, the large dose RBE for cell survival (b ion /b R ) 1/2 approaches (a ion + 2b ion D t )/(a R + 2b R D t ) for doses larger than D t .
For particle therapy with conventional fractionation (e.g., less than 1 or 2 Gy per day as illustrated in the lower right panel of Figs. 5-7), differences in particle RBE related to use of the LQ or LQL dose-response model are likely to be negligible compared to other factors and uncertainties associated with RBE modeling process. However, hypofractionated particle treatments are of increasing interest, and careful analysis of differences in the use of LQ and LQL dose-response models is important. All three models ultimately make predictions about the general trends in a ion and b ion as a function of particle type. The LEM IV, MK, and RMF models all predict a monotonically increasing rise in a ion with increasing LET for protons and helium ions with a CSDA range larger than 0.05 mm (range of LET values in Figs. 5-7) . For carbon ions, the LEM IV and MK models predict that a ion reaches a maximum for a particle LET of about 150 keV/lm and then begins to decrease with increasing LET. In contrast, the RMF model predicts a monotonically increasing trend in a ion regardless of particle LET. It is important to note that the trends in a ion shown in Figs. 5-7 for the RMF model are closely related to the use of the MCDS to compute the relative number of DSB as a function of (Z eff /b) 2 . That is, a ion is a linear-quadratic function RBE DSB [Eqs. (9) and (10)], and the MCDS predicts that RBE DSB increases with increasing LET as illustrated in Fig. 4 . The RMF model per se does not include any specific mechanism of action that would preclude a downward trend in a ion for very high-LET particles. In fact, the downward trend in a ion for high LET particles has been shown to be well described within the framework of the RMF model by incorporating a proximity effect for DSB clustering. 138 The differences in b ion predicted by the LEM IV, MK, and RMF models are substantial and an apt illustration of the challenges associated with understanding and quantifying the dominant biophysical mechanisms of action for large doses of higher LET radiations. The LEM IV predicts that in all cases b ion drops with increasing LET and eventually approaches zero in an ion-specific way. The predicted trend is attributed to the simultaneous decrease in the track diameter with decreasing energy and the increase in the inter-track distance among DSB, at a given dose, with increasing LET. Consequently, the probability for inter-track interaction within a chromatin loop, that is, the induction of two DSB in a loop by two independent tracks, decreases and finally reaches zero, resulting also in a b-value of zero. In the MK model, b ion is considered independent of LET. The RMF predicts a continuous rise of b ion with LET because b ion / RBE DSB ÁRBE DSB . This mechanisms of action arise in the RMF model when pairs of DSB formed by different particle tracks (inter-track effect) dominate the formation of lethal chromosome aberrations and because the kinetics of this binary misrepair process are considered independent of the number of DSB present in the cell.
MODEL TESTING AND CLINICAL VALIDATION OF RBE MODELS
The LEM IV, MK, and RMF models embody many hypothesized mechanisms underlying the biological effectiveness of higher LET particles relative to a low LET reference radiation. As is evident from Figs. 4-7 and Table IV , despite similar-seeming conceptual mechanisms (e.g., interactions of DSB pairs) differences in the model implementations can give rise to significantly different qualitative and quantitative predictions of particle RBE, in particular for higher LET values. For example, the contradictory trends in (b ion /b R ) 1/2 with increasing particle LET seen in the upper right panels of Figs. 5-7 are a dramatic example of how the LEM IV, MK, and RMF predict rapidly diverging trends in a key LQ model parameter with increasing particle LET. Differences are also seen in the impact of (a/b) R on particle RBE, where the effects of ion species are predicted to be much larger by the LEM IV and MK models than by the RMF model for lower doses of protons and helium ions (left panels of FigS. 5 and 6). The models predict also very different trends with respect to saturation effects for carbon ions at high LET (Fig. 7) and with respect to differential effects of different particles with the same LET in a given cell line.
The diverging predictions among models with regard to b ion are related to key mechanistic aspects of the three models. Comparison to experimental data will thus give an important option to challenge these aspects. A careful LQ model analysis of the data from the Particle Irradiation Data Ensemble (PIDE) database # suggests a trend toward decreasing values of b ion with increasing LET. 35 However, a quantitative analysis of these trends is needed to discriminate among the conflicting model predictions concerning b ion given the considerable uncertainties in the measured data. Uncertainties associated with the measurement of cell survival (plating efficiency) and systematic and random uncertainties in particle beam and reference radiation dosimetry 121, [139] [140] [141] [142] [143] need to be considered in that respect.
It is important to note that estimates of a and b (or a/b) are inferred from a regression analysis of measured cell survival data rather than directly measured. As illustrated in the upper right-hand panel of Fig. 3 and investigated in detail in Friedrich et al. 35 , many combinations of a and b can give rise to the same cell survival curve over the range of doses often used in laboratory experiments, that is, an increase (decrease) in a can often be compensated by a decrease (increase) in b over some dose range. The corresponding uncertainties need to be considered in assessments of particle RBE and general trends in a ion and b ion illustrated in the upper left and right panels of Figs. 5-7 . The number and range of dose points covered in laboratory experiments also have a significant impact on assessments of a and b for the reference radiation and particle of interest.
Testing of models and mechanisms of action are most appropriately assessed by comparing model predictions to large datasets that span multiple particle types, kinetic energies, cell lines, and culture conditions. For that purpose, freely accessible and curated repositories of measured data along with the relevant experimental settings, as in the aforementioned PIDE 35 or more specific collections, as for example for proton radiation 14 have been developed. In analyzing the contained data, measured data from multiple cell types, alternate irradiation scenarios, and independent laboratories with different experimental protocols should not, in general, be pooled in a meta analyses, because it might mask important cell-specific trends in cell survival and particle RBE. Data from in vitro and in vivo studies should also not be pooled for similar reasons. The number and range of dose points covered in the individual experiments are also important because a regression analysis of small, noisy datasets gives rise to large uncertainties in the fitted parameters and may affect the anticorrelation between a and b. The radiobiology community is strongly encouraged to quantify and report uncertainties in dosimetric and biological variables. Particular emphasis should be put on the accurate reporting of dose-response data for the reference radiation, as systematic and random errors in data for the reference radiation directly translate into systematic errors in determinations of particle RBE.
In addition to the analysis of data for single (acute) doses of radiation, differences in (b ion /b R ) 1/2 among the LEM IV, MK, and RMF models can potentially be differentiated by comparing model predictions to the results from so-called split-dose experiments. The b-term in the LQ model is attributed in all three models to the accumulation and interactions of DSB within specific subcellular targets (LEM IV and MK models) or the cell nucleus (RMF model) arising from separate particle tracks. These intertrack DSB interactions tend to increase with increasing dose and can be modulated by delivering multiple doses separated by small and large time intervals relative to the kinetics of DSB rejoining. Although not a major focus of the current paper, all three models can incorporate such dose-time fractionation effects by appropriate consideration of the half-time for DSB rejoining.
#
The PIDE database is freely available for downloading after registration on the GSI website: (http://gsi.de/bio-pide).
Split-dose radiation effects have been examined in a number of experiments with charged particles. [144] [145] [146] [147] [148] [149] [150] [151] In general, published studies indicate a reduced or no recovery in cell survival after split doses of high-LET radiation in comparison to low-LET radiation; this trend is consistent with the trend of decreasing b with increasing LET as indicated by experiments using acute irradiations. According to the LQ model, the a/bratio is a key parameter determining fractionation effects. The similarity of the trends of a ion and the concomitant divergence of b ion predictions between the models, as shown in Figs. 5-7 , are expected to lead to different predictions concerning the recovery after split-dose irradiation. In the LEM IV, (b ion /b R ) 1/2 approaches an asymptotic value of zero beyond a particle-specific LET, as shown in the upper panels of Figs. 5-7, compared to a constant or increasing value of (b ion /b R ) 1/2 in the MK and RMF models, respectively. A value of (b ion /b R ) 1/2 = 0 implies no change in the cell surviving fraction as the time interval between doses of high-LET radiation increases whereas (b ion /b R ) 1/2 > 0 implies that cell survival may increase as the time interval between doses increases. However, as discussed already above, a rigorous model comparison to experimental data with thorough uncertainty control is indispensable. It is important to recognize that model-specific predictions of data from split-dose experiments are particularly useful when measured data are reported for fraction sizes comparable to or larger than (a/b). Otherwise, all three models predict little or no change in cell survival in split-dose experiments, that is, the aD term dominates cell killing rather than the bD 2 term. As highlighted in Table IV and the corresponding discussion, RBE effects are believed to arise as a result of DSB interactions in molecular and cellular targets and the ionization density along the trajectory of an ion (i.e., the track structure) and among cells. Focused particle microbeams [152] [153] [154] [155] [156] [157] [158] [159] are a potentially effective way to probe the interaction of the DSB formed along different particle tracks. For example, Girst et al. 160 used live-cell observations and distance tracking of the GFP-tagged DNA damage response protein MDC1 to study the random-walk behavior of DSB formed in chromatin domains by 20 MeV proton and 43 MeV carbon ions. They found that the subrandom-walk confinement of DSB to domains smaller than the diameter of the cell nucleus increases correct break-end rejoining and decreases the chance of long-range movements and, therefore, also decreases the chance pairwise DSB interactions create lethal chromosome aberrations. Schmid et al. 161 have also used microbeam experiments to separate nanometer-scale clustering of DNA lesions to form a DSB from the larger, micrometer scale interactions of two or more DSB to form lethal chromosome aberrations (e.g., dicentrics). The impact on cell survival of microbeam irradiations has been well studied, and it could be shown that the LEM IV concept represents one possible framework for a mechanistic interpretation of the results. 162 The experimental design used in these studies allows the for direct modulation of the inter-track distance while keeping the mean absorbed dose constant; these experiments are an especially direct way to analyze the distance dependence of DSB interactions.
It has long-been recognized that high-LET radiations have the ability to overcome the increased radiation resistance associated with the irradiation of cells under reduced oxygen conditions. 17, 66 At present, the MCDS 16, 17, 54, 66 is the only Monte Carlo model available to quantify the effects of varying levels of oxygen on DSB induction. An empirical model for the oxygen enhancement ratio (OER) can be used in conjunction with the LEM IV to accurately predict cell killing for normoxic and hypoxic conditions. 163, 164 The MK model has also been extended to describe radiation effects in hypoxic cells in Ref. [165] . Because DSB induction decreases almost threefold for anoxic conditions compared to normoxic conditions, 16, 17, 54, 66, [166] [167] [168] comparisons of particle RBE for cells irradiated under anoxic conditions and normoxic levels are potentially very useful as a way to separate the effects of the spatial (intra-and inter-track) distribution of initial DSB from subsequent repair and other processes that contribute to the RBE for cell survival. An understanding of why high-LET radiations are so effective at overcoming tumor hypoxia 66, [169] [170] [171] is also relevant for the individualization and optimization of hadron therapy. 172, 173 The RBE for cell survival is generally considered the most relevant cellular endpoint for predicting the effects of particle RBE on clinical endpoints, for example, local tumor control or normal-tissue toxicity. However, the link between the RBE for reproductive cell survival, as measured by a cell's colony forming ability, and the RBE for treatment complications may be especially tenuous in tissues with little or no ability to recover through cell proliferation, such as in the central nervous system (CNS). There are also many potential cellular mechanisms of action beyond the ones considered in the LEM IV, MK, and RMF models, including bystander effects in vitro [174] [175] [176] [177] [178] [179] [180] [181] [182] and in vivo, 183,184 adaptive responses, 178, 181, [185] [186] [187] [188] immune therapy in combination with radiation, [189] [190] [191] [192] [193] [194] [195] [196] and tumor vasculature effects. 32, 171, 197 For example, there are some reports that high-LET radiations, such as carbon ions and fast neutrons, may be more effective at inducing antitumor immune activity than low-LET radiations. [198] [199] [200] However, the cellular and subcellular mechanisms of action embodied in the LEM IV, MK, and RMF models are still the most plausible explanations for the increased biological effectiveness of high-LET radiations relative to low-LET radiations (i.e., MV x rays) in the treatment of cancer (i.e., clinical endpoints).
Additional studies comparing in vitro (cellular and subcellular) mechanisms of particle RBE to manifestations of particle RBE for clinical endpoints are needed. One fruitful way to approach such comparisons is to compare predictions of the RBE for cell survival from the LEM IV, MK, and RMF models to the RBE derived from clinical experience with carbon ions. Because RBE effects are so much larger for carbon ions than for protons in the therapeutic energy range, tests of the predictive power of cellular models of particle RBE (i.e., the LEM IV, MK, and RMF models) for clinical endpoints are potentially more useful than similar comparisons of relatively low LET therapeutic protons with an RBE in the range from about 1.0 (e.g., skin dose) to 1.4 (tissue distal to a Bragg peak). Comparisons of RBE modeling for the endpoint of reproductive cell survival to clinical outcomes must account for the added complexities related to partial volume effects and mixed radiation fields that might mask the systematic trends in particle RBE for simpler irradiation scenarios, such as the ones that hold in track-segment laboratory experiments with unique ion species, energy, and LET values.
CONCLUSIONS
The present work aimed at transparently highlighting model similarities and differences among the mechanisminspired LEM IV, MK, and RMF models. We approached this review of the models through a quantitative and conceptual inspection of the model inputs and associated mechanisms connecting initial DNA damage across relevant molecular and cellular spatial scales. The corresponding hallmarks and characteristics of each model are compared and contrasted on a neutral basis, that is, without assessing the value or importance of the underlying concepts and quantification of particle RBE. Because the presented results are based on representative (i.e., default) model inputs, except for the value of a/b, additional comparisons of particle RBE are needed for scenarios in which all relevant model inputs are finely tuned to reflect the same experimental parameters (e.g., cell lines, reference radiation, etc.) in order to more fully critique and test alternative and competing mechanisms of action. Still, it is worth noting that all three models have in common the notion of sublethal damage interactions driving the trend toward increasing cell killing at high doses and high LET values. The models differ, however, in the particular way such interaction processes are implemented.
The LEM IV, MK, and RMF models embody different mechanisms of action acting over the spatial scales underlying the biological processing of potentially lethal damage into more lethal forms of damage. Profound differences among the models are revealed in the number and types of input parameters ( Tables I-III) that represent radiation quality, relevant biological targets, and the calculational steps involved in the biological processing of initial damage into lethal damage (Table IV and related discussion). Although sharing the notion of damage interaction, based on these differences, the three considered models make, in particular, remarkably different predictions in (A) the RBE for DSB induction (Fig. 4) , (B) the dependence of b (and therefore a/b) on particle LET (upper right panels of Figs. 5-7), and (C) the RBE for cell survival in the overkill regime (particles with an LET >~150 keV/lm as mainly illustrated in Fig. 7) . Future comparisons of model predictions with experimental data are needed to fully discriminate among competing mechanisms and models of particle RBE.
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